NORML
MAY 26, 2020
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
NORML
FEBRUARY 4, 2021
“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
FEBRUARY 25, 2020
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Additional information on the relationship between cannabis and opioids is available in the NORML fact-sheet here.
Project CBD
JANUARY 1, 2022
New studies highlight therapeutic potential of cannabinoids for cancer, but clinical trials are lacking.
Project CBD
OCTOBER 10, 2019
Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2.
Cannabis Life Network
OCTOBER 14, 2021
Cannabigerol, known as CBG, is a minor cannabinoid that became popular after companies worked around new FDA regulations placed on cannabis producers. Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe. That has since begun to change, especially with a […].
NORML
APRIL 30, 2020
.” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy. ” Among pain patients enrolled in medical cannabis access programs, most subjects report eventually decreasing or even eliminating their use of opiates.
Expert insights. Personalized for you.
265 
Let's personalize your content